معرفی
Manon Penco-Campillo is a Researcher at the Wainwright Laboratory, Loyola University Chicago, where she focuses on developing therapeutic strategies for resistant hepatocellular carcinoma. Her work contributes to the broader mission of cancer research within the university's Cancer Center and involvement in the CMO Masters Program in Biochemistry, Molecular and Cancer Biology.
Her research lies at the intersection of molecular oncology and drug resistance, aiming to overcome treatment barriers in liver cancer. This includes investigating novel biochemical pathways and potential targets for intervention in resistant tumor phenotypes.
The trends in her research focus on cancer therapeutics, particularly in aggressive and treatment-resistant forms of hepatocellular carcinoma. While no publications are listed in the provided text, her work appears aligned with translational cancer research and molecular targeting strategies.
There are no scientific awards listed in the available information.
There is no information available regarding student advising, research grants, or leadership in educational programs.
Manon Penco-Campillo is affiliated with the Wainwright Laboratory, a research unit within Loyola University Chicago’s Cancer Center, which supports advanced studies in cancer biology and therapeutic development.
